I think many will be surprised with how low we actually rise in price if we release good covid data. $40 sounds about right to me.
The AZ vaccine news yesterday claiming to prevent severe disease by 100% is just a taste of the BP headlines to come. The market will probably interpret this to mean that immunomodulating mabs will not be needed as much for covid.
I don’t mean to say $40 is the permanent ceiling, because this data will show the world that lenz works.
But $150-250 price targets on covid results alone? Cmon people.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.